Loading page
Loading page
Loading substance route
Effects vary widely by individual, dose, and context.
The physical effects of deschloroetizolam can be broken down into several components which progressively intensify proportional to dosage.
The cognitive effects of deschloroetizolam can be broken down into several components which progressively intensify proportional to dosage. The general head space of deschloroetizolam is described by many as one of intense sedation and decreased inhibition. It contains a large number of typical depressant cognitive effects. Paradoxical reactions to benzodiazepines such as increased seizures (in epileptics), aggression, increased anxiety, violent behavior, loss of impulse control, irritability and suicidal behavior sometimes occur (although they are rare in the general population, with an incidence rate below 1%). These paradoxical effects occur with greater frequency in recreational abusers, individuals with mental disorders, children, and patients on high-dosage regimes.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Deschloroetizolam is described as extremely psychologically addictive. Compulsive redosing is commonly reported as a characteristic effect, and the drug is classified as habit-forming.
Deschloroetizolam produces severe physical dependence with regular use. Sudden discontinuation can be life-threatening, potentially resulting in seizures or death. Withdrawal symptoms may occur after a few weeks of steady dosing, and a gradual taper over weeks is strongly recommended rather than abrupt cessation.
Deschloroetizolam likely has low toxicity relative to dose when used alone. Overdose may occur when taken in extremely heavy quantities. Thienodiazepine overdose is a medical emergency that may lead to coma, permanent brain injury, or death if not treated promptly.
Paradoxical reactions including delusions may occur but are rare in the general population, with an incidence rate below 1%. These effects occur with greater frequency in recreational abusers, individuals with mental disorders, children, and patients on high-dosage regimes. Delusions may also occur as a symptom of overdose.
While deschloroetizolam itself has anticonvulsant properties, paradoxical increased seizures may rarely occur in epileptic individuals. The primary seizure risk is associated with discontinuation after regular use rather than acute administration. Drugs which lower the seizure threshold should be avoided during withdrawal.
Deschloroetizolam is a designer thienotriazolodiazepine that emerged as a novel psychoactive substance in 2014. The compound is structurally derived from etizolam, differing only by the removal of a chlorine atom from the parent molecule—hence the "deschloro" prefix in its name. This minor…
Thienodiazepines are not scheduled under Canadian controlled substances legislation. However, sale or provision for human consumption is prohibited as deschloroetizolam lacks approval as a medical drug.
Listed as a Schedule III controlled substance since 2017 under Russian drug control legislation.
Classified as a controlled drug under Turkish law. Possession, production, supply, and import are all prohibited activities.
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since July 18, 2019. Production and import with intent to market, administration to others, and trading constitute criminal offenses. Possession is prohibited but not subject to criminal penalty.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics scheduling.
Controlled under the Psychoactive Substances Act 2016, effective May 26, 2016. Production, supply, and import are criminal offenses. Personal possession is not criminalized under this legislation, though the substance remains in a legal grey area.
12 sources cited
